Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Gerlinger

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
The New England Journal of Medicine|March 9, 2012
Intratumor heterogeneity and branched evolution revealed by multiregion sequencingMarco Gerlinger, Andrew J Rowan, Stuart Horswell, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Evolutionary Applications|April 26, 2021
Identifying key questions in the ecology and evolution of cancerAntoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, et al.
Cancer Cell|July 10, 2019
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal CancerAndrew Woolston, Khurum Khan, Georgia Spain, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
The New England Journal of Medicine|March 9, 2012
Intratumor heterogeneity and branched evolution revealed by multiregion sequencingMarco Gerlinger, Andrew J Rowan, Stuart Horswell, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Evolutionary Applications|April 26, 2021
Identifying key questions in the ecology and evolution of cancerAntoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, et al.
Cancer Cell|July 10, 2019
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal CancerAndrew Woolston, Khurum Khan, Georgia Spain, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Pageof 7